334 related articles for article (PubMed ID: 32140928)
1. Evidence that TNF-β suppresses osteoblast differentiation of mesenchymal stem cells and resveratrol reverses it through modulation of NF-κB, Sirt1 and Runx2.
Constanze B; Popper B; Aggarwal BB; Shakibaei M
Cell Tissue Res; 2020 Jul; 381(1):83-98. PubMed ID: 32140928
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin-1 (SIRT1) is required for promoting chondrogenic differentiation of mesenchymal stem cells.
Buhrmann C; Busch F; Shayan P; Shakibaei M
J Biol Chem; 2014 Aug; 289(32):22048-62. PubMed ID: 24962570
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol mediated modulation of Sirt-1/Runx2 promotes osteogenic differentiation of mesenchymal stem cells: potential role of Runx2 deacetylation.
Shakibaei M; Shayan P; Busch F; Aldinger C; Buhrmann C; Lueders C; Mobasheri A
PLoS One; 2012; 7(4):e35712. PubMed ID: 22539994
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol downregulates inflammatory pathway activated by lymphotoxin α (TNF-β) in articular chondrocytes: Comparison with TNF-α.
Buhrmann C; Popper B; Aggarwal BB; Shakibaei M
PLoS One; 2017; 12(11):e0186993. PubMed ID: 29095837
[TBL] [Abstract][Full Text] [Related]
5. Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells.
Huang H; Zhao N; Xu X; Xu Y; Li S; Zhang J; Yang P
Cell Prolif; 2011 Oct; 44(5):420-7. PubMed ID: 21951285
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha inhibits osteogenic differentiation of pre-osteoblasts by downregulation of EphB4 signaling via activated nuclear factor-kappaB signaling pathway.
Wang LM; Zhao N; Zhang J; Sun QF; Yang CZ; Yang PS
J Periodontal Res; 2018 Feb; 53(1):66-72. PubMed ID: 28857167
[TBL] [Abstract][Full Text] [Related]
7. Sirt1 overexpression protects murine osteoblasts against TNF-α-induced injury in vitro by suppressing the NF-κB signaling pathway.
Huang W; Shang WL; Wang HD; Wu WW; Hou SX
Acta Pharmacol Sin; 2012 May; 33(5):668-74. PubMed ID: 22447223
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol alleviates osteoporosis through improving the osteogenic differentiation of bone marrow mesenchymal stem cells.
Chen XH; Shi ZG; Lin HB; Wu F; Zheng F; Wu CF; Huang MW
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6352-6359. PubMed ID: 31364143
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Runx2 signaling by TNF-α in ST2 murine bone marrow stromal cells undergoing osteogenic differentiation.
Ye X; Huang H; Zhao N; Zhang J; Yang P
In Vitro Cell Dev Biol Anim; 2016 Dec; 52(10):1026-1033. PubMed ID: 27401008
[TBL] [Abstract][Full Text] [Related]
10. TNF-α-induced NF-κB activation upregulates microRNA-150-3p and inhibits osteogenesis of mesenchymal stem cells by targeting β-catenin.
Wang N; Zhou Z; Wu T; Liu W; Yin P; Pan C; Yu X
Open Biol; 2016 Mar; 6(3):. PubMed ID: 26935950
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis.
Tseng PC; Hou SM; Chen RJ; Peng HW; Hsieh CF; Kuo ML; Yen ML
J Bone Miner Res; 2011 Oct; 26(10):2552-63. PubMed ID: 21713995
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol Suppresses Cross-Talk between Colorectal Cancer Cells and Stromal Cells in Multicellular Tumor Microenvironment: A Bridge between In Vitro and In Vivo Tumor Microenvironment Study.
Buhrmann C; Shayan P; Brockmueller A; Shakibaei M
Molecules; 2020 Sep; 25(18):. PubMed ID: 32962102
[TBL] [Abstract][Full Text] [Related]
13. SIRT1 is a positive regulator of the master osteoblast transcription factor, RUNX2.
Zainabadi K; Liu CJ; Guarente L
PLoS One; 2017; 12(5):e0178520. PubMed ID: 28542607
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous up-regulation of SIRT1 during osteogenesis contributes to stem cells' resistance to oxidative stress.
Li M; Yan J; Chen X; Tam W; Zhou L; Liu T; Pan G; Lin J; Yang H; Pei M; He F
J Cell Biochem; 2018 Jun; 119(6):4928-4944. PubMed ID: 29380418
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress induces imbalance of adipogenic/osteoblastic lineage commitment in mesenchymal stem cells through decreasing SIRT1 functions.
Lin CH; Li NT; Cheng HS; Yen ML
J Cell Mol Med; 2018 Feb; 22(2):786-796. PubMed ID: 28975701
[TBL] [Abstract][Full Text] [Related]
16. SIRT1 was involved in TNF-α-promoted osteogenic differentiation of human DPSCs through Wnt/β-catenin signal.
Feng G; Zheng K; Song D; Xu K; Huang D; Zhang Y; Cao P; Shen S; Zhang J; Feng X; Zhang D
In Vitro Cell Dev Biol Anim; 2016 Dec; 52(10):1001-1011. PubMed ID: 27530621
[TBL] [Abstract][Full Text] [Related]
17. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
J Bone Miner Res; 2006 Jul; 21(7):993-1002. PubMed ID: 16813520
[TBL] [Abstract][Full Text] [Related]
18. Sirt1 Promotes Osteogenic Differentiation and Increases Alveolar Bone Mass via Bmi1 Activation in Mice.
Wang H; Hu Z; Wu J; Mei Y; Zhang Q; Zhang H; Miao D; Sun W
J Bone Miner Res; 2019 Jun; 34(6):1169-1181. PubMed ID: 30690778
[TBL] [Abstract][Full Text] [Related]
19. TNF-α triggers osteogenic differentiation of human dental pulp stem cells via the NF-κB signalling pathway.
Feng X; Feng G; Xing J; Shen B; Li L; Tan W; Xu Y; Liu S; Liu H; Jiang J; Wu H; Tao T; Gu Z
Cell Biol Int; 2013 Dec; 37(12):1267-75. PubMed ID: 23765556
[TBL] [Abstract][Full Text] [Related]
20. Effects of SIRT1 on Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in Type 2 Diabetic Patients.
Deng X; Deng L; Xu M; Sun Y; Yang M
Endocr Metab Immune Disord Drug Targets; 2023; 23(8):1077-1086. PubMed ID: 36624641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
